慢性心力衰竭患者接受心脏再同步化治疗后长期死亡率及相关危险因素的多中心研究
该多中心研究纳入2001年3月至2013年6月三家医疗中心接受心脏再同步化治疗(CRT)的200例慢性心力衰竭住院患者,随访0.5至12年。全因死亡率为25.50%(51/200),缺血性心肌病(ICM)患者死亡率33.90%(20/59)高于非缺血性心肌病(NICM)患者21.98%(31/141)。心脏性死亡36例(70.59%),其中猝死21例(41.18%),心脏性死亡发生率显著高于非心脏性死亡(P<0.01)。
要点
- 全因死亡率为25.50%(51/200),ICM患者死亡率33.90%(20/59)高于NICM患者21.98%(31/141)。
- 心脏性死亡36例(70.59%),其中猝死21例(41.18%),心脏性死亡发生率显著高于非心脏性死亡(P<0.01)。
- CRT-P组死亡40/152例(78.43%),CRT-D组死亡11/48例(21.57%)(χ2=3.13,P<0.01)。
核心结论
- 该队列CRT全因死亡率为25.50%,ICM患者死亡率高于NICM患者,猝死为最高死亡原因,CRT-P患者死亡率显著高于CRT-D患者,心脏性死亡患者CRT植入前左心房和左心室更大、心功能更差。
研究设计与样本
- 多中心研究,纳入2001年3月至2013年6月三家医疗中心(白求恩国际和平医院、中国人民解放军沈阳军区总医院、中国人民解放军第251医院)接受CRT的慢性心力衰竭住院患者200例(男154例,平均年龄(60.57±11.75)岁),其中ICM 59例,随访0.5至12年,分析死亡及相关原因、超声心动图参数。
主要发现
- 全因死亡51/200例(25.50%),ICM死亡20/59例(33.90%),NICM死亡31/141例(21.98%)。
- 心脏性死亡36例(70.59%),其中猝死21例(41.18%);非心脏性死亡13例(25.49%),死因不明2例(3.92%);心脏性死亡发生率显著高于非心脏性死亡(P<0.01)。
- 心脏性死亡主要见于NICM(28/36,77.78%),非心脏性死亡主要见于ICM(11/13,84.62%,P<0.01)。
- 心脏性死亡患者较非心脏性死亡患者更年轻(P<0.01),左心房舒张末期内径(LAEDD)和左心室舒张末期内径(LVEDD)更大(P<0.01),左心室射血分数(LVEF)更低(P<0.05),肺动脉压力更高(P<0.05)。
- CRT-P组152例中死亡40例(78.43%),CRT-D组48例中死亡11例(21.57%)(χ2=3.13,P<0.01);CRT-D组死亡原因构成以非心脏性死亡为主,CRT-P组以心脏性死亡为主(χ2=2.66,P<0.01);CRT-P组猝死率显著高于CRT-D组(χ2=2.16,P<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze long-term mortality and patients characteristics of cardiac resynchronization therapy (CRT) for patients with chronic heart failure. Methods: In-patients with chronic heart failure who received CRT in the three medical centers(Bethune International Peace Hospital, General Hospital of Shenyang Military Command of Chinese People's Liberation Army, and 251 Hospital of People's Liberation Army)from March 2001 to June 2013 were included.Mortality and related causes, echocardiographic parameters were analyzed. Results: A total of 200 patients were treated with CRT therapy (154 males, mean age (60.57±11.75) years), 59 cases suffered from ischemic cardiomyopathy (ICM), patients were followed up from 0.5 to 12 years.The all-cause mortality rate was 25.50% (51/200), 20 out of 59 (33.90%) ICM patients died, as compared with 31 deaths out of 141 (21.98%) in non-ischemic cardiomyopath (NICM) patients.Thirty-six patients died due to cardiac death (70.59%), in which sudden death occurred in 21 patients (41.18%). Non-cardiac death occurred in 13 patients (25.49%), two patients died due to unknown reasons (3.92%). Incidence of cardiac death was significantly higher than non-cardiac death (P<0.01). The main cause for cardiac death was NICM (28/36, 77.78%), while the main cause of non-cardiac death was ICM (11/13, 84.62%, P<0.01). Patients died due to cardiac death were younger (P<0.01) and had larger left atrial end-diastolic diameter (LAEDD) and left ventricular end-diastolic diameter (LVEDD) (P<0.01), lower left ventricular ejection fraction (LVEF)(P<0.05), higher pulmonary artery pressure(P<0.05) compared to patients with non-cardiac death.One hundred and fifty-two cases received CRT-P and 48 cases received CRT-D, there were no significant differences in gender, the course of heart failure, serum creatinine levels, pre-operative and post-operative QRS duration and so on between the CRT-P and CRT-D groups(all P>0.05). Eleven out of the 48 cases with CRT-D died during the following-up (21.57%) , while 40 out of 152 cases with CRT-P died (78.43%) during the following-up(χ2=3.13, P<0.01). The proportional mortality rate in cause of death in patients with CRT-D was non-cardiac while in those with CRT-P was cardiac (χ2=2.66, P<0.01), sudden death rate was also significantly higher in CRT-P group than in CRT-D group (χ2=2.16, P<0.01). By using single- and multiple-factor Cox regression analysis, age, disease course, pre-operation QRS duration and NYHA classification were predictors of cardiac death(all P<0.05). Conclusions: The all-cause mortality of CRT is 25.50% in this patient cohort, mortality rate was higher in ICM patients than in NICM patients.Sudden cardiac death rate was the highest mortality reason.The mortality rate of patients with CRT-P was significantly higher than in patients with CRT-D.In comparison with patients of non-cardiac death, patients of cardiac death had larger left atrium and left ventricle and worse heart function before CRT implantation.
引用
- Qi SY, Wang DM, Yu HB, et al. [A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure receiving resynchronization therapy]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 27903393. doi:10.3760/cma.j.issn.0253-3758.2016.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。